These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 16170353

  • 1. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
    Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y, Kaneki M.
    Oncogene; 2006 Jan 12; 25(2):176-85. PubMed ID: 16170353
    [Abstract] [Full Text] [Related]

  • 2. Sirt1 modulates premature senescence-like phenotype in human endothelial cells.
    Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y.
    J Mol Cell Cardiol; 2007 Nov 12; 43(5):571-9. PubMed ID: 17916362
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 4. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418
    [Abstract] [Full Text] [Related]

  • 5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV.
    Cancer Res; 2006 May 15; 66(10):5304-13. PubMed ID: 16707456
    [Abstract] [Full Text] [Related]

  • 7. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
    Perrault R, Wright B, Storie B, Hatherell A, Zahradka P.
    Cell Signal; 2011 Apr 15; 23(4):739-46. PubMed ID: 21215800
    [Abstract] [Full Text] [Related]

  • 8. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R, Vasilcanu D, Sehat B, Yin S, Girnita A, Axelson M, Girnita L.
    Mol Pharmacol; 2008 Mar 07; 73(3):930-9. PubMed ID: 18070930
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 11. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY, Small GW, Orlowski RZ.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):33-47. PubMed ID: 16807678
    [Abstract] [Full Text] [Related]

  • 12. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
    Borowiec AS, Hague F, Harir N, Guénin S, Guerineau F, Gouilleux F, Roudbaraki M, Lassoued K, Ouadid-Ahidouch H.
    J Cell Physiol; 2007 Sep 01; 212(3):690-701. PubMed ID: 17520698
    [Abstract] [Full Text] [Related]

  • 13. Two distinct regulatory mechanisms of neurotransmitter release by phosphatidylinositol 3-kinase.
    Itakura M, Yamamori S, Kuwahara R, Sekiguchi M, Takahashi M.
    J Neurochem; 2005 Jul 01; 94(2):502-9. PubMed ID: 15998300
    [Abstract] [Full Text] [Related]

  • 14. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 15. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug 22; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 16. Hyperoxia induces Egr-1 expression through activation of extracellular signal-regulated kinase 1/2 pathway.
    Jones N, Agani FH.
    J Cell Physiol; 2003 Aug 22; 196(2):326-33. PubMed ID: 12811826
    [Abstract] [Full Text] [Related]

  • 17. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE.
    Cancer Res; 2010 May 15; 70(10):4151-62. PubMed ID: 20460524
    [Abstract] [Full Text] [Related]

  • 18. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
    He S, Dibas A, Yorio T, Prasanna G.
    Exp Biol Med (Maywood); 2007 Mar 15; 232(3):370-84. PubMed ID: 17327470
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.
    Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S.
    J Cell Physiol; 2003 Aug 15; 196(2):370-7. PubMed ID: 12811831
    [Abstract] [Full Text] [Related]

  • 20. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
    Matsuda K, Idezawa T, You XJ, Kothari NH, Fan H, Korc M.
    Cancer Res; 2002 Oct 01; 62(19):5611-7. PubMed ID: 12359775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.